LaunchBio, UNC’s Catalyst for Rare Diseases, the Rare Disease InfoHub and NCBiotech are partnering to hold a two-day forum focused on nonprofit disease foundation investments and the development of rare disease therapeutics on September 25 and September 26.
LaunchBio’s Invest in Cures, explores how disease foundations are accelerating the pace of commercialization of new therapies and cures for patients. On Wednesday, September 25, LaunchBio welcomes disease foundations to discuss their investment philosophies, explain their fund and deal structures, and describe how they are using deep scientific knowledge to validate early stage technologies and syndicate with other investors.
UNC’s Catalyst for Rare Diseases and the Rare Disease InfoHub are presenting Rare Disease Forum on Thursday, September 26, for stakeholders to discuss the status and potential changes required to overcome the research, clinical, regulatory and economic barriers to effective treatment of rare diseases.
These events represent a significant opportunity for foundations, patient groups, investors and companies to share recent advances and best practices in the emerging field of disease foundation sponsored investing and the ever-evolving field of rare disease drug development. Time for informal networking will be provided throughout both days of the events.
Concurrent with the two-day forum, NCBiotech and LaunchBio will be working with the attending disease foundations and investors to arrange invited meetings with companies and entrepreneurs as one-on-one interactions to discuss collaborations and/or funding opportunities.
Events from the Triad